| Literature DB >> 32325183 |
Kurt A Zimmerman1, Katharina Hopp2, Michal Mrug3.
Abstract
Polycystic Kidney Disease (PKD) triggers a robust immune system response including changes in both innate and adaptive immunity. These changes involve immune cells (e.g., macrophages and T cells) as well as cytokines and chemokines (e.g., MCP-1) that regulate the production, differentiation, homing, and various functions of these cells. This review is focused on the role of the immune system and its associated factors in the pathogenesis of PKDs as evidenced by data from cell-based systems, animal models, and PKD patients. It also highlights relevant pre-clinical and clinical studies that point to specific immune system components as promising candidates for the development of prognostic biomarkers and therapeutic strategies to improve PKD outcomes. Published by Elsevier Inc.Entities:
Keywords: ADPKD; ARPKD; Autosomal dominant polycystic kidney disease; Autosomal recessive polycystic kidney disease; Chemokines, Macrophages; Immune response; Kidney function; T cells
Year: 2020 PMID: 32325183 PMCID: PMC8063685 DOI: 10.1016/j.cellsig.2020.109647
Source DB: PubMed Journal: Cell Signal ISSN: 0898-6568 Impact factor: 4.315